116 related articles for article (PubMed ID: 34694788)
1. Comment on "Censoring Trace-Level Environmental Data: Statistical Analysis Considerations to Limit Bias".
Hites RA
Environ Sci Technol; 2021 Nov; 55(22):15554-15555. PubMed ID: 34694788
[No Abstract] [Full Text] [Related]
2. Response to Comment on "Censoring Trace-Level Environmental Data: Statistical Analysis Considerations to Limit Bias".
George BJ; Thomas KW; Simmons JE
Environ Sci Technol; 2021 Nov; 55(22):15556-15557. PubMed ID: 34704749
[No Abstract] [Full Text] [Related]
3. Censoring Trace-Level Environmental Data: Statistical Analysis Considerations to Limit Bias.
George BJ; Gains-Germain L; Broms K; Black K; Furman M; Hays MD; Thomas KW; Simmons JE
Environ Sci Technol; 2021 Mar; 55(6):3786-3795. PubMed ID: 33625843
[TBL] [Abstract][Full Text] [Related]
4. Adjusting win statistics for dependent censoring.
Dong G; Huang B; Wang D; Verbeeck J; Wang J; Hoaglin DC
Pharm Stat; 2021 May; 20(3):440-450. PubMed ID: 33247544
[TBL] [Abstract][Full Text] [Related]
5. GRADE Guidelines: 29. Rating the certainty in time-to-event outcomes-Study limitations due to censoring of participants with missing data in intervention studies.
Goldkuhle M; Bender R; Akl EA; van Dalen EC; Nevitt S; Mustafa RA; Guyatt GH; Trivella M; Djulbegovic B; Schünemann H; Cinquini M; Kreuzberger N; Skoetz N;
J Clin Epidemiol; 2021 Jan; 129():126-137. PubMed ID: 33007458
[TBL] [Abstract][Full Text] [Related]
6. Limitation of inverse probability-of-censoring weights in estimating survival in the presence of strong selection bias.
Howe CJ; Cole SR; Chmiel JS; Muñoz A
Am J Epidemiol; 2011 Mar; 173(5):569-77. PubMed ID: 21289029
[TBL] [Abstract][Full Text] [Related]
7. The inverse-probability-of-censoring weighting (IPCW) adjusted win ratio statistic: an unbiased estimator in the presence of independent censoring.
Dong G; Mao L; Huang B; Gamalo-Siebers M; Wang J; Yu G; Hoaglin DC
J Biopharm Stat; 2020 Sep; 30(5):882-899. PubMed ID: 32552451
[TBL] [Abstract][Full Text] [Related]
8. Causal inference for long-term survival in randomised trials with treatment switching: Should re-censoring be applied when estimating counterfactual survival times?
Latimer NR; White IR; Abrams KR; Siebert U
Stat Methods Med Res; 2019 Aug; 28(8):2475-2493. PubMed ID: 29940824
[TBL] [Abstract][Full Text] [Related]
9. Estimating correlation with multiply censored data arising from the adjustment of singly censored data.
Newton E; Rudel R
Environ Sci Technol; 2007 Jan; 41(1):221-8. PubMed ID: 17265951
[TBL] [Abstract][Full Text] [Related]
10. The role of censoring on progression free survival: oncologist discretion advised.
Prasad V; Bilal U
Eur J Cancer; 2015 Nov; 51(16):2269-71. PubMed ID: 26259493
[TBL] [Abstract][Full Text] [Related]
11. A Practical Overview and Reporting Strategies for Statistical Analysis of Survival Studies.
Dey T; Mukherjee A; Chakraborty S
Chest; 2020 Jul; 158(1S):S39-S48. PubMed ID: 32658651
[TBL] [Abstract][Full Text] [Related]
12. Selection bias introduced by informative censoring in studies examining effects of vaccination in infancy.
López-López JA; Sterne JAC; Higgins JPT
Int J Epidemiol; 2019 Dec; 48(6):2001-2009. PubMed ID: 31071211
[TBL] [Abstract][Full Text] [Related]
13. Impact of informative censoring on the Kaplan-Meier estimate of progression-free survival in phase II clinical trials.
Campigotto F; Weller E
J Clin Oncol; 2014 Sep; 32(27):3068-74. PubMed ID: 25113767
[TBL] [Abstract][Full Text] [Related]
14. Correcting for dependent censoring in routine outcome monitoring data by applying the inverse probability censoring weighted estimator.
Willems S; Schat A; van Noorden MS; Fiocco M
Stat Methods Med Res; 2018 Feb; 27(2):323-335. PubMed ID: 26988930
[TBL] [Abstract][Full Text] [Related]
15. Making sense of clinical trial data: is inverse probability of censoring weighted analysis the answer to crossover bias?
Rimawi M; Hilsenbeck SG
J Clin Oncol; 2012 Feb; 30(4):453-8. PubMed ID: 22215751
[TBL] [Abstract][Full Text] [Related]
16. Interpretation of tests of heterogeneity and bias in meta-analysis.
Ioannidis JP
J Eval Clin Pract; 2008 Oct; 14(5):951-7. PubMed ID: 19018930
[TBL] [Abstract][Full Text] [Related]
17. Methods for Handling Left-Censored Data in Quantitative Microbial Risk Assessment.
Canales RA; Wilson AM; Pearce-Walker JI; Verhougstraete MP; Reynolds KA
Appl Environ Microbiol; 2018 Oct; 84(20):. PubMed ID: 30120116
[TBL] [Abstract][Full Text] [Related]
18. Method of median semi-variance for the analysis of left-censored data: comparison with other techniques using environmental data.
Zoffoli HJ; Varella CA; do Amaral-Sobrinho NM; Zonta E; Tolón-Becerra A
Chemosphere; 2013 Nov; 93(9):1701-9. PubMed ID: 23830887
[TBL] [Abstract][Full Text] [Related]
19. Bias due to left truncation and left censoring in longitudinal studies of developmental and disease processes.
Cain KC; Harlow SD; Little RJ; Nan B; Yosef M; Taffe JR; Elliott MR
Am J Epidemiol; 2011 May; 173(9):1078-84. PubMed ID: 21422059
[TBL] [Abstract][Full Text] [Related]
20. Selection Bias Due to Loss to Follow Up in Cohort Studies.
Howe CJ; Cole SR; Lau B; Napravnik S; Eron JJ
Epidemiology; 2016 Jan; 27(1):91-7. PubMed ID: 26484424
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
